Treatment of Adult Soft Tissue Sarcoma: Old Concepts, New Insights, and Potential for Drug Discovery

被引:11
作者
Aragon-Ching, Jeanny B. [1 ]
Maki, Robert G. [2 ,3 ]
机构
[1] George Washington Univ, Dept Med, Div Hematol & Oncol, Med Ctr, Washington, DC 20037 USA
[2] Mt Sinai Sch Med, Dept Med, Tisch Canc Inst, New York, NY USA
[3] Mt Sinai Sch Med, Dept Pediat, Tisch Canc Inst, New York, NY USA
关键词
Soft tissue sarcoma; Targeted agents; Chemotherapy; GIANT-CELL TUMOR; GROWTH-FACTOR-I; PHASE-II; DERMATOFIBROSARCOMA PROTUBERANS; INTERGROUP RHABDOMYOSARCOMA; IMATINIB MESYLATE; BETA-CATENIN; ALVEOLAR RHABDOMYOSARCOMA; COMBINATION CHEMOTHERAPY; ADJUVANT RADIATION;
D O I
10.3109/07357907.2012.658936
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Soft tissue sarcomas are a heterogeneous group of mesenchymal tumors that vary in their behavior as well as treatment. Certain histologic subtypes predict for response to particular chemotherapy drugs, while molecular genetics not only increasingly aid in the diagnosis but also has an emerging role in the identification of potential targets for drug therapy. Herein we review the varying soft tissue sarcoma subtypes, their staging, and management. Furthermore, improvement in the understanding of novel mechanisms involved in soft tissue sarcomas lends insight into the compelling role of the use of newer agents with promising results that are discussed.
引用
收藏
页码:300 / 308
页数:9
相关论文
共 95 条
[1]  
AGULNIK M, 2009, J CLIN ONCOL, V27
[2]   Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity [J].
Alektiar, KM ;
Leung, D ;
Zelefsky, MJ ;
Brennan, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1643-1650
[3]  
Alman BA, 1997, AM J PATHOL, V151, P329
[4]  
[Anonymous], J CLIN ONCOL
[5]  
[Anonymous], J CLIN ONCOL
[6]  
[Anonymous], 2000, COCHRANE DATABASE SY
[7]   Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803 [J].
Arndt, Carola A. S. ;
Stoner, Julie A. ;
Hawkins, Douglas S. ;
Rodeberg, David A. ;
Hayes-Jordan, Andrea A. ;
Paidas, Charles N. ;
Parham, David M. ;
Teot, Lisa A. ;
Wharam, Moody D. ;
Breneman, John C. ;
Donaldson, Sarah S. ;
Anderson, James R. ;
Meyer, William H. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) :5182-5188
[8]  
Ayalon D., 2001, Growth Hormone and IGF Research, V11, P289, DOI 10.1054/ghir.2001.0244
[9]  
Azzarelli A, 2001, CANCER, V92, P1259, DOI 10.1002/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO
[10]  
2-Y